Cite
Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial
MLA
Malcolm David Mason, et al. “Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial.” Clinical Oncology, vol. 25, May 2013, pp. 318–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........132159688d146730d5b2fa3f8af98b23&authtype=sso&custid=ns315887.
APA
Malcolm David Mason, Daniel M. Aebersold, David P. Dearnaley, George N. Thalmann, Noel W. Clarke, J.S. de Bono, A.W.S. Ritchie, Mona Parmar, Nicholas D. James, J.M. Russell, Chris Parker, & Matthew R. Sydes. (2013). Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial. Clinical Oncology, 25, 318–320.
Chicago
Malcolm David Mason, Daniel M. Aebersold, David P. Dearnaley, George N. Thalmann, Noel W. Clarke, J.S. de Bono, A.W.S. Ritchie, et al. 2013. “Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial.” Clinical Oncology 25 (May): 318–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........132159688d146730d5b2fa3f8af98b23&authtype=sso&custid=ns315887.